Author(s): Jyotsna Singh [1] Selling price of HCV drugs far higher than production cost, all because of pro-industry patent regime On occasion of World Hepatitis Day on July 28, the World Health Organization (WHO) and its alliance partners have called… Continue Reading →
Hope for hep-C patients: Context and Background Today, the Bench of Intellectual Property Appellate Board, comprising Justice Prabha Sridevan (Chairperson) and Mr DPS Parmar (Technical Member), set aside the first ever product patent on a medicine granted in India to… Continue Reading →
© 2023 Kractivism — Powered by WordPress
Theme by Anders Noren — Up ↑